EUVIMEDEUVIMED entdecken
Crossref

Adropin in polycystic ovarian syndrome: expression and impact on human granulosa cell function

Patrycja Kurowska iD, Monika Dawid, Natalia Respekta-Długosz, Julia Oprocha, Oliwia Szkraba, Marek Skrzypski, Noémie Couty, Christelle Ramé, Fabrice Guérif, Jakub Wyroba, Joanna Kochan, Lechosław Gajda und 3 weitere

Journal of Endocrinology · 2026

DOI: 10.1530/joe-25-0240 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endocrinology, 2026. Verfasst von Patrycja Kurowska und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University in…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Granulosa Cells, Intercellular Signaling Peptides and Proteins, Peptides. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Graphical abstract Abstract Adropin is a novel protein that regulates energy homeostasis. Serum and follicular fluid (FF) levels of adropin are decreased in women with polycystic ovarian syndrome (PCOS); however, its role in ovarian function remains unknown. The aims of this study were to determine the expression of adropin and its receptor G protein-coupled receptor 19 (GPR19), in human granulosa cells (GC), its immunolocalization, and its in vitro effects on GC function. Blood plasma, FF, and GC samples were obtained from normal-weight, obese, and women diagnosed with or without PCOS (n = 8). The in vitro effects of adropin on GC proliferation, apoptosis, cell cycle progression, and steroidogenesis were analyzed. The results revealed that adropin plasma concentration was decreased in obese patients, with a similar reduction observed in obese patients with PCOS, whereas GPR19 expression was decreased in the GC of obese and PCOS women, as well as in obese patients with PCOS. We noted that in all investigated patient groups, adropin reduced GC proliferation and cell cycle progression, negatively influenced steroidogenic enzyme levels, and promoted apoptosis. Such disruptions in GC function are likely to impair ovarian follicular maturation and contribute to the subfertility commonly observed in PCOS. These alterations may ultimately affect oocyte competence and ovarian responsiveness, parameters that are clinically relevant for in vitro fertilization outcomes. Our findings suggest that adropin may act as a novel regulator of ovarian function and could contribute to the pathophysiology of PCOS, highlighting its potential clinical value as a marker of altered ovarian follicular function in affected women.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeGranulosa CellsIntercellular Signaling Peptides and ProteinsPeptidesHumansFemaleApoptosisCell ProliferationObesityAdultFollicular FluidCells, CulturedCell Cycle

Stichwörter der Autor:innen

PCOSadropinapoptosisobesityproliferationsteroidogenesis

Substanzen

Intercellular Signaling Peptides and ProteinsEnho protein, humanPeptides

Autor:innen und Institutionen

  • Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Faculty of Biology, Jagiellonian University in Krakow , Krakow, Poland.
  • Doctoral School of Exact and Natural Sciences, Jagiellonian University in Krakow , Krakow, Poland.
  • Department of Animal Physiology and Biochemistry, Poznan University of Life Sciences , Poznan, Poland.
  • National Research Institute for Agriculture, Food and The Environment, Unité Physiologie de la Reproduction et des Comportements , Nouzilly, France.
  • Malopolski Institute of Fertility Diagnostics and Treatment - KrakOvi , Krakow, Poland.
  • Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Krakow University , Krakow, Poland.

ORCID-Profile: Patrycja Kurowska, Agnieszka Rak

Zitieren

APA

Kurowska, P., Dawid, M., Respekta-Długosz, N., Oprocha, J., Szkraba, O., Skrzypski, M., Couty, N., Ramé, C., Guérif, F., Wyroba, J., Kochan, J., Gajda, L., Trzcińska, M., Dupont, J., & Rak, A. (2026). Adropin in polycystic ovarian syndrome: expression and impact on human granulosa cell function. Journal of Endocrinology. https://doi.org/10.1530/joe-25-0240

Vancouver

Kurowska P, Dawid M, Respekta-Długosz N, Oprocha J, Szkraba O, Skrzypski M, et al. Adropin in polycystic ovarian syndrome: expression and impact on human granulosa cell function. Journal of Endocrinology. 2026. doi:10.1530/joe-25-0240

BibTeX
@article{Kurowska2026,
  author = {Kurowska, Patrycja and Dawid, Monika and Respekta-Długosz, Natalia and Oprocha, Julia and Szkraba, Oliwia and Skrzypski, Marek and Couty, Noémie and Ramé, Christelle and Guérif, Fabrice and Wyroba, Jakub and Kochan, Joanna and Gajda, Lechosław and Trzcińska, Monika and Dupont, Joelle and Rak, Agnieszka},
  title = {Adropin in polycystic ovarian syndrome: expression and impact on human granulosa cell function},
  journal = {Journal of Endocrinology},
  year = {2026},
  doi = {10.1530/joe-25-0240}
}
Kostenlos starten →